PII, (Pharmaceutics International, Inc.) has launched PII Drug Delivery Solutions to provide clients with product development tools to help meet the challenges of new chemical entities (NCEs) and product life cycle management (LCM).

The goal of PII Drug Delivery Solutions is to provide dedicated business development, centers of technical excellence, proactive partnering and integrated support from PII core resources. According to the company, its portfolio of in-house and partnered drug delivery technologies can be used to assist clients with product development needs from early-stage drug candidate optimization through to the revitalization of a marketed compound.

Steve King, senior vice president of PII, commented, “Our dedicated business development team, led by Robin Mitchell and Susan Wiggins, has extensive experience in drug delivery and contract services. We aim to proactively bring creative problem solving solutions and product concepts to our clients. PII already has a very powerful portfolio of technology platforms at our disposal and intends to build on this during 2009.”

“PII has quietly developed some impressive technologies of its own — nanoparticle formulations and MedCrystalForms’ mixed phase co-crystals for enhanced drug bioavailability for example. Through our partnerships with companies like Penwest, we can tackle a broad range of controlled release challenges too,” said Robin Mitchell, senior director drug delivery solutions, adding, “Susan Wiggins and I are very excited about the role that we can play to strengthen our clients’ business success in today’s very competitive markets.”